196 related articles for article (PubMed ID: 32518053)
21. PAPA spectrum disorders.
Genovese G; Moltrasio C; Garcovich S; Marzano AV
G Ital Dermatol Venereol; 2020 Oct; 155(5):542-550. PubMed ID: 32618443
[TBL] [Abstract][Full Text] [Related]
22. Novel PSTPIP1 gene mutation in pyoderma gangrenosum, acne and suppurative hidradenitis syndrome.
Saito N; Minami-Hori M; Nagahata H; Nozaki H; Iinuma S; Igawa S; Kanno K; Kishibe M; Kanazawa N; Ishida-Yamamoto A
J Dermatol; 2018 Aug; 45(8):e213-e214. PubMed ID: 29575118
[No Abstract] [Full Text] [Related]
23. Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients.
Join-Lambert O; Duchatelet S; Delage M; Miskinyte S; Coignard H; Lemarchand N; Alemy-Carreau M; Lortholary O; Nassif X; Hovnanian A; Nassif A
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S66-9. PubMed ID: 26470620
[TBL] [Abstract][Full Text] [Related]
24. Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome: A Case Report and Literature Review.
Huang J; Tsang LS; Shi W; Li J
Front Med (Lausanne); 2022; 9():856786. PubMed ID: 35402426
[TBL] [Abstract][Full Text] [Related]
25. Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected?
Zivanovic D; Masirevic I; Ruzicka T; Braun-Falco M; Nikolic M
Australas J Dermatol; 2017 May; 58(2):e54-e59. PubMed ID: 26831949
[TBL] [Abstract][Full Text] [Related]
26. PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome.
Calderón-Castrat X; Bancalari-Díaz D; Román-Curto C; Romo-Melgar A; Amorós-Cerdán D; Alcaraz-Mas LA; Fernández-López E; Cañueto J
Br J Dermatol; 2016 Jul; 175(1):194-8. PubMed ID: 26713508
[No Abstract] [Full Text] [Related]
27. Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery.
Marzano AV; Ishak RS; Colombo A; Caroli F; Crosti C
Dermatology; 2012; 225(3):215-9. PubMed ID: 23171584
[TBL] [Abstract][Full Text] [Related]
28. Is SAPHO Syndrome Linked to PASH Syndrome and Hidradenitis Suppurativa by Nicastrin Mutation? A Case Report.
Li C; Xu H; Wang B
J Rheumatol; 2018 Nov; 45(11):1605-1607. PubMed ID: 30068763
[No Abstract] [Full Text] [Related]
29. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
Scheinfeld N
Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
[TBL] [Abstract][Full Text] [Related]
30. PAPA-like syndrome with heterozygous mutation in the MEFV gene.
O'Connor C; Kiely L; Heffron C; Ryan J; Bennett M
Clin Exp Dermatol; 2022 Mar; 47(3):642-645. PubMed ID: 34882829
[TBL] [Abstract][Full Text] [Related]
31. Is PASH Syndrome a Biofilm Disease?: A Case Series and Review of the Literature.
Ead JK; Snyder RJ; Wise J; Cuffy C; Jafary H; Fischborn K
Wounds; 2018 Aug; 30(8):216-223. PubMed ID: 30212364
[TBL] [Abstract][Full Text] [Related]
32. Case Report: Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne: A Single-Center Experience and Literature Review.
Wang Y; Wu N; Yu K; Shen M
Front Immunol; 2021; 12():735851. PubMed ID: 34745107
[TBL] [Abstract][Full Text] [Related]
33. Successful combined antibiotic therapy with oral clindamycin and oral rifampicin for pyoderma gangrenosum in patient with PASH syndrome.
Lamiaux M; Dabouz F; Wantz M; Lebas D; Lasek A; Courivaud D; Modiano P
JAAD Case Rep; 2018 Jan; 4(1):17-21. PubMed ID: 29296643
[No Abstract] [Full Text] [Related]
34. Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne).
Demidowich AP; Freeman AF; Kuhns DB; Aksentijevich I; Gallin JI; Turner ML; Kastner DL; Holland SM
Arthritis Rheum; 2012 Jun; 64(6):2022-7. PubMed ID: 22161697
[TBL] [Abstract][Full Text] [Related]
35. Clinical and genetic analysis of the first Mexican patient with a diagnosis of pyogenic sterile arthritis, pyoderma gangrenosum and acne (PAPA) syndrome.
Fuentes-Nava AG; Fierro-Arias L; Zenteno JC; Apam-Garduño D
Clin Exp Dermatol; 2024 Mar; 49(4):441-443. PubMed ID: 37942851
[No Abstract] [Full Text] [Related]
36. Recognizing syndromic hidradenitis suppurativa: a review of the literature.
Gasparic J; Theut Riis P; Jemec GB
J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1809-1816. PubMed ID: 28696038
[TBL] [Abstract][Full Text] [Related]
37. Pyoderma gangrenosum and suppurative hidradenitis association, overlap or spectrum of the same disease? Case report and discussion.
Turcu G; Ioana Nedelcu R; Teodora Nedelcu I; Hodorogea A; Balaban M; Brinzea A; Nichita L; Gabriela Popp C; Andrada Zurac S; Theodor Andrei R
Exp Ther Med; 2020 Jul; 20(1):38-41. PubMed ID: 32508990
[TBL] [Abstract][Full Text] [Related]
38. Phenotypes and Pathophysiology of Syndromic Hidradenitis Suppurativa: Different Faces of the Same Disease? A Systematic Review.
Nikolakis G; Kaleta KP; Vaiopoulos AG; Wolter K; Baroud S; Wojas-Pelc A; Zouboulis CC
Dermatology; 2021; 237(5):673-697. PubMed ID: 32942279
[TBL] [Abstract][Full Text] [Related]
39. PASS Syndrome: An IL-1-Driven Autoinflammatory Disease.
Leuenberger M; Berner J; Di Lucca J; Fischer L; Kaparos N; Conrad C; Hohl D; So A; Gilliet M
Dermatology; 2016; 232(2):254-8. PubMed ID: 26919742
[TBL] [Abstract][Full Text] [Related]
40. Case Report: PsAPSASH syndrome: an alternative phenotype of syndromic hidradenitis suppurativa treated with the IL-17A inhibitor secukinumab.
Nikolakis G; Kreibich K; Vaiopoulos A; Kaleta K; Talas J; Becker M; Zouboulis CC
F1000Res; 2021; 10():381. PubMed ID: 34540202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
